Aarey Drugs submitted a clarification to NSE regarding a PAT figure mismatch in its Q3 FY26 results due to a clerical error.
The company has uploaded revised Integrated Financial Results with an acknowledgement number of 150465.
The revision was submitted on 11-Apr-2026 for the quarter ended 31-Dec-2025 via the NEAPS utility.